Skip to main content
User account menu
Log in
X
Main navigation
About
Overview
Leadership and Structure
Partners and Product Developers
Activity Hubs
Technology Accelerator
Design to Delivery
Business Market Dynamics and Commercialization
Capacity Strengthening Engagement and Mentorship
Clinical Trials
Products
Cabotegravir Injectable Depot
Cabotegravir Injectable Depot with Levonorgestrel
Cabotegravir Pellet Implant
Cabotegravir Pellet Implant with Levonorgestrel
Extended Release Dapivirine Vaginal Film
Extended Release Dapivirine Vaginal Film with Levonorgestrel
Griffithsin Fast Dissolving Vaginal Insert
Non-ARV/Non-Hormonal Multi-Purpose Vaginal Ring
TAF/EVG Fast Dissolving Vaginal Insert
News and More
Feature Stories and Profiles
MATRIX in the News
News Releases, Fact Sheets and QAs
HIV in the News
Research Highlights
Abstracts, Briefs and Publications
Meeting Materials, Presentations and Reports
Meetings and Webinars of Interest
People
Email Groups
Resources
MATRIX Policies
Regulatory Documents
Search
Home
Activity Hubs
Design to Delivery
End-User Acceptability (D2D Pillar 1)
Design Consultations
Design Consultations
Zimbabwe Design Consultations
DC1, September 2022
Kenya Design Consultations
DC1, November 2022
